In various cancer models, Wee1 inhibition promotes accumulation of cytosolic dsDNA, leading to activation of the cGAS-STING pathway (Figure 1), increased type I interferon target gene expression when delivered alone (195), as well as in combination with ATR inhibitors (196) or immune checkpoint blockade (197). Here, WEE1 is linked to cancer.